WAT - Waters Corporation
NYSE
->
Healthcare
->
Diagnostics & Research
Milford,
United States
Type: Equity
WAT price evolution
WAT
| (in millions $) | 28 Oct 2024 | 30 Jun 2024 | 30 Apr 2024 | 31 Jan 2024 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $326.43 | $337.29 | $395.08 | |
| Short term investments | $0.93 | $0.92 | $0.9 | |
| Net receivables | $669.53 | $610.09 | $626.33 | $702.17 |
| Inventory | $518.99 | $522.93 | $538.63 | $516.24 |
| Total current assets | $1647.72 | $1603.68 | $1642.96 | $1614.38 |
| Long term investments | ||||
| Property, plant & equipment | $719.27 | $717.23 | $714.66 | $639.07 |
| Goodwill & intangible assets | $1894.19 | $1908.97 | $1934.63 | |
| Total noncurrent assets | $2845.36 | $2866.01 | $2873.99 | |
| Total investments | $0.93 | $0.92 | $0.9 | |
| Total assets | $4511.62 | $4449.05 | $4508.96 | $4626.85 |
| Current liabilities | ||||
| Accounts payable | $94.6 | $78.44 | $86.22 | $84.7 |
| Deferred revenue | $316.93 | $336.72 | $256.68 | |
| Short long term debt | $26.37 | $76.88 | $77.83 | |
| Total current liabilities | $816.04 | $762.53 | $848.46 | $789.58 |
| Long term debt | $1826.25 | $2062.36 | $2005.76 | $2355.51 |
| Total noncurrent liabilities | $2274.55 | $2403.98 | $2686.93 | |
| Total debt | $2088.72 | $2138.57 | $2442.26 | |
| Total liabilities | $2908.52 | $3037.08 | $3252.44 | $3476.51 |
| Shareholders' equity | ||||
| Retained earnings | $9557.26 | $9395.75 | $9253.02 | $9150.82 |
| Other shareholder equity | -$129.47 | -$148.2 | -$141.22 | $1150.34 |
| Total shareholder equity | $1411.97 | $1256.53 | $1150.34 | |
| (in millions $) | 31 Jan 2024 | 31 Jan 2023 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $395.08 | $480.53 | $501.23 | $436.69 |
| Short term investments | $0.9 | $0.86 | $68.05 | $6.45 |
| Net receivables | $702.17 | $722.89 | $612.65 | $573.32 |
| Inventory | $516.24 | $455.71 | $356.1 | $304.28 |
| Total current assets | $1614.38 | $1659.99 | $1628.94 | $1401.03 |
| Long term investments | ||||
| Property, plant & equipment | $639.07 | $582.22 | $632.65 | $587.25 |
| Goodwill & intangible assets | $1934.63 | $657.73 | $680.27 | $703.01 |
| Total noncurrent assets | $2873.99 | $1517.55 | $1465.99 | $1438.89 |
| Total investments | $0.9 | $0.86 | $68.05 | $6.45 |
| Total assets | $4626.85 | $3281.45 | $3094.93 | $2839.92 |
| Current liabilities | ||||
| Accounts payable | $84.7 | $93.3 | $96.8 | $72.21 |
| Deferred revenue | $256.68 | $227.91 | $227.56 | $198.24 |
| Short long term debt | $77.83 | $76.43 | $27.91 | $177.76 |
| Total current liabilities | $789.58 | $785.74 | $680.51 | $804.98 |
| Long term debt | $2355.51 | $1574.88 | $1573.49 | $1274.71 |
| Total noncurrent liabilities | $2686.93 | $1991.23 | $2046.87 | $1802.79 |
| Total debt | $2442.26 | $1663.41 | $1601.4 | $1452.48 |
| Total liabilities | $3476.51 | $2776.97 | $2727.38 | $2607.78 |
| Shareholders' equity | ||||
| Retained earnings | $9150.82 | $8508.59 | $7800.83 | $7107.99 |
| Other shareholder equity | $1150.34 | $504.49 | -$111.86 | -$117.94 |
| Total shareholder equity | $1150.34 | $504.49 | $367.55 | $232.14 |
| (in millions $) | 28 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 | 31 Jan 2024 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $740.3 | $708.53 | $636.84 | $819.47 |
| Cost of revenue | $288.24 | $261.79 | ||
| Gross Profit | $438.65 | $420.29 | $375.05 | $501.11 |
| Operating activities | ||||
| Research & development | $46.18 | $44.59 | ||
| Selling, general & administrative | $173.25 | $174.54 | ||
| Total operating expenses | $226.19 | $231.17 | $241.21 | $236.89 |
| Operating income | $189.11 | $133.85 | ||
| Income from continuing operations | ||||
| EBIT | $193.14 | $140.38 | ||
| Income tax expense | $32.11 | $26.68 | $12.66 | $21.39 |
| Interest expense | -$17.18 | $23.73 | $25.52 | -$26.07 |
| Net income | ||||
| Net income | $161.5 | $142.74 | $102.2 | $216.21 |
| Income (for common shares) | $142.74 | $102.2 | ||
| (in millions $) | 31 Jan 2024 | 31 Dec 2022 | 31 Jan 2022 | 31 Dec 2020 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $2956.42 | $2971.96 | $2365.36 | |
| Cost of revenue | $1248.18 | $1006.69 | ||
| Gross Profit | $1761.19 | $1723.77 | $1358.68 | |
| Operating activities | ||||
| Research & development | $176.19 | $140.78 | ||
| Selling, general & administrative | $658.03 | $553.7 | ||
| Total operating expenses | $943.52 | $850.38 | $714.96 | |
| Operating income | $873.39 | $643.71 | ||
| Income from continuing operations | ||||
| EBIT | $886.64 | $659.98 | ||
| Income tax expense | $94.01 | $130.09 | $89.34 | |
| Interest expense | -$82.24 | $48.8 | $49.07 | |
| Net income | ||||
| Net income | $642.23 | $707.75 | $521.57 | |
| Income (for common shares) | $707.75 | $521.57 | ||
| (in millions $) | 28 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 | 31 Jan 2024 |
|---|---|---|---|---|
| Net income | $142.74 | $102.2 | ||
| Operating activities | ||||
| Depreciation | $47.23 | $48.51 | ||
| Business acquisitions & disposals | ||||
| Stock-based compensation | $11.43 | $10.91 | ||
| Total cash flows from operations | $54.53 | $262.87 | ||
| Investing activities | ||||
| Capital expenditures | -$36.1 | -$28.66 | ||
| Investments | -$0.01 | -$1.09 | ||
| Total cash flows from investing | -$91.91 | -$36.12 | -$29.74 | -$1442.27 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | $7.66 | $0.84 | ||
| Net borrowings | -$50 | -$300 | ||
| Total cash flows from financing | -$503.1 | -$34.04 | -$292.18 | $754.95 |
| Effect of exchange rate | $8.46 | $4.75 | $1.26 | -$0.95 |
| Change in cash and equivalents | -$64.56 | -$10.86 | -$57.79 | -$85.45 |
| (in millions $) | 31 Jan 2024 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Net income | $707.75 | $692.84 | $521.57 | |
| Operating activities | ||||
| Depreciation | $130.42 | $131.68 | $125.36 | |
| Business acquisitions & disposals | -$80.55 | |||
| Stock-based compensation | $42.56 | $29.92 | $36.87 | |
| Total cash flows from operations | $611.66 | $747.27 | $790.51 | |
| Investing activities | ||||
| Capital expenditures | -$175.92 | -$161.27 | -$172.38 | |
| Investments | $75.49 | -$63.36 | -$11.16 | |
| Total cash flows from investing | -$1442.27 | -$107.97 | -$231.63 | -$264.09 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | -$583.26 | -$593.29 | -$130.38 | |
| Net borrowings | $60 | $151.46 | -$325.37 | |
| Total cash flows from financing | $754.95 | -$509.63 | -$438.27 | -$440.5 |
| Effect of exchange rate | -$0.95 | -$14.77 | -$12.83 | $15.07 |
| Change in cash and equivalents | -$85.45 | -$20.7 | $64.54 | $100.98 |
News
Fundamentals
| Market cap | $22.45B |
|---|---|
| Enterprise value | N/A |
| Shares outstanding | 59.37M |
| Revenue | $2.91B |
|---|---|
| EBITDA | N/A |
| EBIT | N/A |
| Net Income | $622.64M |
| Revenue Q/Q | 4.02% |
| Revenue Y/Y | -3.01% |
| P/E ratio | 36.06 |
|---|---|
| EV/Sales | N/A |
| EV/EBITDA | N/A |
| EV/EBIT | N/A |
| P/S ratio | 7.73 |
| P/B ratio | N/A |
| Book/Share | N/A |
| Cash/Share | N/A |
| EPS | $10.49 |
|---|---|
| ROA | 13.76% |
| ROE | N/A |
| Debt/Equity | 3.02 |
|---|---|
| Net debt/EBITDA | N/A |
| Current ratio | 2.02 |
| Quick ratio | 1.38 |